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Tularemia -United States, 1990-2000
Tularemia is a zoonotic disease caused by the gramnegative coccobacillus Francisella tularensis. Known also as "rabbit fever" and "deer fly fever," tularemia was first described in the United States in 1911 and has been reported from all states except Hawaii. Tularemia was removed from the list of nationally notifiable diseases in 1994, but increased concern about potential use of F. tularensis as a biological weapon led to its reinstatement in 2000. This report summarizes tularemia cases reported to CDC during 1990-2000, which indicate a low level of natural transmission. Understanding the epidemiology of tularemia in the United States enables clinicians and public health practitioners to recognize unusual patterns of disease occurrence that might signal an outbreak or a bioterrorism event.
Tularemia characteristically presents as an acute febrile illness. Various clinical manifestations can occur depending on the route of infection and host response, including an ulcer at the site of cutaneous or mucous membrane inoculation (Figure 1) , pharyngitis, ocular lesions, regional lymphadenopathy, and pneumonia. A diagnosis of tularemia can be laboratoryconfirmed by culture of F. tularensis from clinical specimens or by a fourfold titer change of serum antibodies against F. tularensis. Presumptive diagnosis can be made by detecting F. tularensis antigens with fluorescent assays or by a single elevated antibody level (1) . For purposes of national surveillance, confirmed and probable tularemia cases are defined as clinically compatible illness with confirmatory or presumptive laboratory evidence of F. tularensis infection, respectively. Before September 1996, because of ambiguity in the case definition, some cases of tularemia might have been considered confirmed by fluorescent assay alone. Case status is determined at the state level. For the purposes of this report, any case reported to CDC was assumed to have laboratory evidence of infection. Similar results were obtained when the analysis was limited to cases with documented confirmed or probable status.
During 1990-2000, a total of 1,368 cases of tularemia were reported to CDC from 44 states, averaging 124 cases (range: 86-193) per year; 807 cases (59%) were reported as confirmed and 85 cases (6%) were reported as probable; the status of 476 cases is unknown. Most (91%) unclassified cases were reported (8) and various laboratory exposures (9) . Outbreaks of pneumonic tularemia, particularly in low-incidence areas, should prompt consideration of bioterrorism (10) .
The high incidence of tularemia among males and among children aged <10 years might be associated with increased opportunity for exposure to infected ticks or animals, less use of personal protective measures against tick bites, or diagnostic or reporting bias. The high incidence among American Indians/Alaska Natives might be associated with their increased risk for exposure; outbreaks of tularemia have been reported on reservations in Montana and South Dakota, where a high prevalence of tularemia infection was found in ticks and dogs (4, 5) .
The findings in this report are subject to several limitations, including underreporting and the lack of documented laboratory confirmation for all cases. Surveillance for tularemia could be improved by documenting laboratory confirmation of diagnosis and by including additional data (e.g., clinical presentation, exposure history, and outcome).
Following a dramatic decline in the second half of the 20th century, the incidence of tularemia in the United States remains low. The epidemiologic characteristics described in this report provide a background against which unusual patterns of disease occurrence, including bioterrorism events, may be recognized more quickly. Rate * Per 100,000 population, calculated using 1995 population estimates.
Point-of-Purchase Tobacco Environments and Variation by Store Type -United States, 1999
To promote its products, the tobacco industry spent $8.2 billion on marketing in 1999, an increase of $1.5 billion over the previous year (1) . Tobacco advertising in various media increases tobacco consumption (2) and adolescents are more susceptible than adults to being influenced by some forms of tobacco advertising (3) . To describe the retail tobacco advertising and marketing environment, researchers from the Robert Wood Johnson Foundation-sponsored ImpacTeen Project* collected and analyzed store observation data in 163 communities throughout the United States. This report summarizes the extent of point-of-purchase (POP) tobacco advertising and marketing found in various types of stores.
The findings in this report indicate that certain retail environments frequented by teenagers heavily promote tobacco use. To reduce demand for tobacco products among adolescents, public health efforts should address POP environment exposure to tobacco advertising and marketing.
During a 4-month period in 1999, ImpacTeen researchers observed POP environments in 3,031 retail outlets in 163 communities with public schools participating in the nationally representative Monitoring the Future (MTF) study of eighth-, 10th-, and 12th-grade students (4). Private and magnet schools (comprising approximately 20% of the original sample) were not included in this study. Community boundaries were defined by the area from which each school drew at least 80% of its student population. Random samples of up to 30 retailers per community were drawn from lists of stores selling tobacco and/or liquor products as identified by their Standard Industrial Classifications (SIC) Index codes † . Two additional samples of 10 stores each were drawn as replacements for any stores on the original list that did not meet study criteria (i.e., those that had ceased business, had relocated, were not open during the days observers were on site, or did not sell tobacco products). If field observers could not reach the desired sample size of 30 using the original and replacement lists of retailers, they added tobacco retailers identified on site. Of the 3,031 observed stores, 2,309 (76.2%) were from the original sample, 355 (11.7%) were from randomly generated replacement lists, and 367 (12.1%) were added in the field based on study protocol. Overall, 2,999 (98.9%) of all observed stores were tobacco retailers and were eligible for inclusion in the study.
Field observers collected information on the presence of various POP tobacco environment features including 1) tobacco product placement (self-service versus clerkassisted); 2) promotions (multipack/cents-off discounts and gift-with-purchase offers); 3) tobacco-branded functional objects (free items provided by the industry such as counter change mats or shopping baskets displaying the sponsoring company's logo); 4) presence and extent of exterior and interior advertisements (such as those indicating special prices); 5) presence of low-height interior advertising or advertisements directly in the line of sight of very young children (at a height of <3½ feet above the floor); and 6) tobacco-control signage (including Food and Drug Administration [FDA] § -or industry-sponsored signage, health warnings, or messages indicating that identification is required to purchase tobacco products). Data were weighted to account for both the community-level multistage sampling procedures and the store selection probabilities. The GENMOD procedure in SAS v.8 was used to run generalized estimating equations that accounted for community clustering while specifying a binomial distribution and a logit link function. Results were expressed as unadjusted odds ratios and 95% Wald confidence intervals. For all analyses, supermarkets were used as the referent category.
Some form of tobacco POP presence (i.e., interior or exterior advertising, self-service pack placement, multipack discounts, tobacco-branded functional objects, or vending machines) was observed in 92.1% of the stores: self-service cigarette pack placement in 36.4%, multipack discounts in 25.2%, and at least one tobacco-branded functional object in 68.5%. Most (80%) retailers displayed interior tobacco advertising; 22.8% had high levels of interior advertising (i.e., advertisements outside areas where tobacco products were sold or displayed), and 42.9% had low-height advertisements. Exterior tobacco advertisements were observed in 58.9% of the stores, with 40.4% having high levels of exterior advertising (i.e., five or more advertisements or at least one advertisement >1 foot in any dimension). Some form of tobacco advertising (interior or exterior) was present in 84.1% of the stores. Convenience/gas retailers were significantly more likely to have five of the six POP measures, convenience and liquor stores were significantly more likely to have four of the measures, and drug stores were significantly less likely to have two of the measures (Table 1) .
Tobacco-control signage was observed in 65.8% of the stores (Table 2) . Forty-eight percent of stores had industrysponsored signage warning minors that proof of age is required to purchase tobacco products (e.g., "We Card" signs), 32.7% had FDA-sponsored signage, 4.1% had health warning signs, and 6.3% had other minors' access signs. Convenience stores and convenience/gas stores were significantly more likely to have industry-sponsored signs. Both gas stations and liquor stores were significantly less likely to have health warning signage. Editorial Note: The findings in this report indicate that convenience, convenience/gas, and liquor stores were most likely to have pro-tobacco environments (i.e., environments in which patrons are exposed to high levels of tobacco-related advertisements, promotions, and functional objects). Convenience and convenience/gas stores account for the largest share of retail tobacco sales (5) . Because 75% of teenagers shop at convenience or convenience/gas stores at least once a week (6), adolescents will continue to be exposed to high levels of tobacco POP influence unless pro-tobacco marketing in these retail environments is restricted.
Although virtually all tobacco retailers in this study had some form of tobacco POP presence, fewer of these stores had a visible tobacco-control environment, and even fewer displayed health warnings. Although this study did not measure the extent of tobacco-specific control signage, observers generally reported that pro-tobacco signage predominated.
The findings in this report are subject to at least three limitations. First, only retailers in communities with public schools participating in the MTF study were included in this report and might not be representative of all stores in the United States. Second, although original and replacement retailer selection was random, no effort was made to ensure that the various store types were represented proportionally. Third, some minor differences were observed between both replacement stores and stores added in the field when compared with other stores. Replacement stores were less likely to have multipack promotions, counter signage, and FDA-sponsored signage. Added stores were less likely to have functional objects or FDA-sponsored signage, were more likely to have packs available via self-service, and showed some differences in store type (fewer other and corner/grocery stores, and more liquor stores). No significant differences were observed for either replacement or added stores with regard to either presence or extent of exterior or interior tobacco advertising.
Exposure to POP advertising and marketing influences youth access to, experimentation with, and purchase of cigarettes (7) (8) (9) . Public health efforts should include strategies to decrease pro-tobacco POP environment exposure and reduce demand for tobacco products among adolescents. Recommendations include eliminating or severely restricting self-service product displays, free samples, functional objects, and advertisements (10) . Public practitioners or policy makers may facilitate the implementation of these recommendations by working with retailer associations and within communities to decrease overall POP tobacco-promotion activities. Initial efforts should target those store types most frequented by adolescents in which a pro-tobacco environment predominates.
Variation in Homicide Risk During Infancy -United States, 1989-1998
Homicide is the 15th leading cause of death during the first year of life (i.e., infancy) in the United States. In addition, the risk for homicide is greater in infancy than in any other year of childhood before age 17 years (1) and is greatest during the first 4 months of life (2) . To determine how the risk for homicide varied by week during infancy and by day during the first week of life, CDC analyzed death certificate data for 1989-1998. This report summarizes the results of this analysis, which indicated that risk for infant homicide is greatest on the day of birth. Efforts to prevent infant homicides should focus on early infancy.
Most infant deaths are certified by medical examiners or coroners. Statistical information from death certificates is consolidated into a national database through the National Vital Statistics System (1). Information on U.S. resident infant homicide deaths for 1989-1998 was obtained from CDC's National Center for Health Statistics. An infant was defined as a person aged <1 year at death. Homicide was defined as an underlying cause coded through the International Classification of Disease, Ninth Revision, codes E960-E969 (3). Age at death in days was defined as one plus the difference between the dates of death and birth recorded on the death certificate. An infant killed on its date of birth had an age at death of 1 day. In comparison, homicide rates during different time periods within infancy were presented as rates per person-years of exposure. The U.S. infant population during 1989-1998 accounted for 39,941,628 person years of exposure, of which days of birth accounted for 109,354 person years, and the remainder of infancy accounted for 39,832,274 person years.
During 1989-1998, a total of 3,312 infant homicides were reported for a rate of 8.3 per 100,000 person years. Of these, 81 (2.4%) were excluded because of a missing date of birth. The proportion of homicides occurring each week of infancy varied, with 9.1% of homicides occurring during the first week of life ( Figure 1) ; a secondary peak in the distribution of homicides occurred at week 8.
Among homicides during the first week of life, 82.6% occurred on the day of birth, 9.2% on the second day, and 8.2% during the remainder of the week. After the first 2 days of life, the number of deaths in the remainder of the first week was comparable to the number of deaths in the second week of life. Overall, 243 (7.3%) of all infant homicides occurred on the day of birth. When homicide rates on the first day of life and during the remainder of infancy were compared with homicide rates during later age groups (Figure 2 Age (Weeks) Editorial Note: The findings in this report highlight the high risk for homicide on the day of birth. Risk is comparatively small after the day of birth, even during the highest risk periods of adulthood. Among homicides on the first day of life, 95% of the victims are not born in a hospital. Among homicides later in infancy, 8% of infants are not born in a hospital (2) . Among homicides during the first week of life, 89% of known perpetrators are female, usually the mother (4). Mothers who kill their infants are more likely to be adolescents and have a history of mental illness (2,5). The secondary peak in risk in week 8 might reflect the peak in the daily duration of crying among normal infants between weeks 6 and 8 (6) . The limitations of these findings include the potential under and overascertainment of homicides through vital records. Infant homicides probably are underascertained by being either labeled as unintentional injuries or attributed to sudden infant death syndrome (SIDS) (7). Underascertainment probably does not vary by week of life and is unlikely to account for the observed pattern. Overascertainment might have occurred if some of the cases classified as homicides on the first day of life were actually stillbirths. It is not known what percent of cases of homicide on the day of birth might have been stillbirths. However, the percentage is probably small because medical examiners usually will attribute a death to infanticide only if autopsy evidence indicates that respiration had occurred, no evidence indicates death from natural causes, and circumstantial evidence is consistent with homicide (8) .
Preventing out-of-hospital births among high-risk women might help reduce the number of homicides on the day of birth. Home visitation and parenting programs, especially those that begin during pregnancy, might help reduce child abuse during infancy by focusing on the weeks of greatest risk early in infancy (9). Seventeen stool specimens, which were collected from 11 patients and tested positive by the rapid assay, were re-evaluated at WSLH. Six of these stool specimens were in EcoFix (Meridian Bioscience Inc., Cincinnati, Ohio), eight were in Cary-Blair transport media, and three were formalin fixed. All 17 specimens tested negative for Cryptosporidium at WSLH using the hot safranin stain and MeriFluor (Meridian Bioscience Inc., Cincinnati, Ohio) Cryptosporidium/Giardia direct fluorescent antibody kit with concentrated specimens.
Public Health Dispatch
For comparison, WSLH repeated the rapid assay tests of the specimens using Becton, Dickinson, and Company ColorPAC TM Cryptosporidium/Giardia rapid assay from the same lot used at the southeastern Wisconsin laboratory. Eleven (65%) of the 17 stool specimens were positive on repeat testing, including five (83%) specimens in EcoFix, four (50%) of specimens in Cary-Blair transport media, and two (67%) of the formalin-fixed specimens. The ColorPAC TM kits also were used to test four known Cryptosporidium negative stool specimens, and two of these tests were positive. Becton, Dickinson, and Company has voluntarily recalled this lot from laboratories.
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Notice to Readers
Pseudomonas aeruginosa Infections Associated with Defective Bronchoscopes
Investigators at Johns Hopkins University have notified CDC of Pseudomonas aeruginosa infections and colonizations that may be associated with defective bronchoscopes. The source of bacteria is believed to be a loose port, which might act as a reservoir for Pseudomonas aeruginosa infections.
On Additional information is available from Olympus, telephone (800) 848-9024, and from the Food and Drug Administration, telephone (800) 638-2041.
Notice to Readers
Shortage of Varicella and Measles, Mumps and Rubella Vaccines and Interim
Recommendations from the Advisory Committee on Immunization Practices 
Varicella Vaccine
Although the duration of the varicella vaccine shortage is uncertain, Merck predicts that the shortage will be resolved by late spring or early summer 2002. The annual need for varicella vaccine in the United States is about 6 to 7 million doses or 500,000-583,000 doses per month. Because of supply decreases, by March 4, approximately 1.1 million doses were on back order for both public and private sectors. Merck estimates an average of 60 days to fill these orders. Meanwhile, shortages are expected nationwide.
Interim ACIP Recommendations for Use of Varicella Vaccine
Varicella is a more severe disease among adolescents and adults; however, the highest incidence of disease is among elementary school aged-children (1,2). Until adequate supplies of varicella vaccine are available, ACIP recommends that all vaccine providers in the United States delay administration of the routine childhood varicella vaccine dose from age 12-18 months until age 18-24 months (3, 4 
Measles, Mumps and Rubella Vaccine
Although the duration of the shortage is uncertain, the manufacturer predicts that problems with the MMR vaccine supply should be resolved in 1-3 months. The annual need for MMR vaccine in the United States is about 13 million doses. The average number of MMR doses shipped during January-September 2001 was 943,000 doses; during October-November 2001, an average of 586,000 doses was shipped; during December 2001-February 2002, an average of 819,000 doses was shipped each month. As of March 4, a total of 1,077,670 doses was on back order for both the public and private sectors. As of February 28, 2002, the manufacturer projects that 5.6 million doses will be supplied during March-May 2002.
Interim ACIP Recommendation for Use of MMR Vaccine
Two doses of MMR vaccine, separated by at least a month and administered on or after the first birthday, are recommended for children, adolescents, and adults who lack adequate documentation of vaccination or other acceptable evidence of immunity (5) . The first dose is recommended at age 12-15 months and the second dose at age 4-6 years. If providers are unable to obtain sufficient amounts of MMR vaccine to implement fully ACIP recommendations for MMR vaccination, ACIP recommends that they defer the second MMR dose. Because of the severity of measles in young children, providers should not delay administration of the first dose of the MMR series.
Tracking and Recall
Records should be maintained for children who experience a delay in administration of either varicella or MMR vaccines so they can be recalled when vaccine becomes available. The latest information about vaccine supply issues is available at http://www.cdc.gov/nip/news/shortages. 
Notice to Readers
Availability of Continuing Education CD-ROM Program on Strategies to Increase Adult Vaccination Rates
The Association of Teachers of Preventive Medicine (ATPM) and the National Immunization Program (NIP)/CDC have released "Increasing Adult Vaccination Rates: WhatWorks," an interactive instructional program on CD-ROM that offers primary-care providers strategies to increase vaccination rates among their adult patients.
The program gives users the opportunity to test their knowledge of vaccine usage and explore facts about vaccinepreventable diseases; access reference materials and answers to frequently asked questions; review information about effective strategies (e.g., standing orders, chart reminders, and mailed/telephoned reminders) and test their knowledge of how to best implement these strategies; and develop a customized adult vaccination action plan for their practice.
The CD-ROM features web links to appropriate resources, predominantly those on the NIP/CDC Web site. The program is approved for 2 hours of Continuing Medical Education credit, 2.3 hours Continuing Nursing Education credit, and 0.2 hours Continuing Education units through CDC.
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